ENT endoscopy Market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031

“ENT endoscope” is a tubular device that is used in a minimally invasive medical diagnostic procedure called “ENT endoscopy” where an organ’s internal surface can be assessed. As per the latest research, the ENT endoscopy market is forecasted to experience exponential growth during 2021-2031. The Global market for ENT endoscopy is expected to grow at a CAGR of a big percentage in the forecast period (2021-2031).

What is Driving Demand for ENT endoscopy?

Essential drivers of the ENT endoscopy market are diseases like sinusitis and fast advancement in medical technology. In 2020, surgeries like Endoscopic sinus surgery, neurosurgery, skull-based surgery, and sales of other endoscopy devices led to the surpassing of endoscopic market size and giving it a benefit as compared to the previous years. The sales of ENT endoscopy went through a good growth phase, leading to crucial challenges that are to be faced by manufacturers but the market is expected to gain momentum in the forecast period since there are great medical and technological advancements taking place widely.

The high prevalence of Chronic Sinusitis is one of the major drivers of the endoscopy market, lead to the inflow of patients in hospitals and ENT clinics which in turn lead to the increase of production of ENT tools leading to the gross profit of the entire market. It demonstrates that the Endoscopy market can be interdependent on other markets and the profits can go hand in hand.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13159

What is the Repercussion of the Pandemic on the Growth of the ENT Endoscopy Market?

Due to the Covid-19 pandemic, the ENT endoscope market got affected badly as the endoscopic services were under secondary procedures which were to be shut down but the sales of ENT tools were actively done in the Medical and Healthcare sectors during the treatment of COVID-19 positive patients which kept a stable momentum of the market. Yet, an analytics firm “GlobalData” predicts a heavy surge in the ENT endoscopy market sales in 2021 and in the forecast period (2021-2031) after facing a huge number of losses in previous years.

The US and Canada ENT endoscopy Market Outlook

A good growth rate of the ENT endoscopy market is expected to expand for the US due to an increase in the number of endoscopic procedures performed all around the region, any of the incident and prevalent ENT related disorders like an Ear infection (Otis media), Gastric reflux, dizziness, Dysphagia (difficulty swallowing) and Hearing loss lead to the skyrocketing of the ENT endoscopy market since more and more advancements are being done for the production of the ENT tools.

The Canadian endoscopy market on the other hand is also expected to grow with good and steady growth but comparatively lesser than that of the American market. Endoscopic ear surgery which is a new technique and surgery with fast recovery with lesser post-surgical infections is in high demand due to which these turn out to be the driving factors of the ENT endoscopy market.

Who are the Key Manufacturers and Suppliers of ENT endoscopy?

Top leading manufacturers and suppliers of ENT endoscopy include

  • Olympus
  • Pentax
  • Fujifilm
  • Karl Storz
  • Arthrex
  • Boston Scientific
  • Conmed
  • Cook Medical

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13159

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Terminal sterilization Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2031

According to the latest research by Future Market Insights, the terminal sterilization market is set to witness steady growth during 2021-2031. Significant Demand for terminal sterilization due to pandemic situation, with optimistic growth outlook in the long-run. Rising demand from the medical device industry will increase the opportunities in near future, however, the service of terminal sterilization in the pharmaceutical sector will provide momentum.

What is Driving Demand for Terminal sterilization?

Growing demand for terminal sterilization for drug products amongst end-user continues to drive demand for terminal sterilization. Moreover, the launch of innovative product and technological advancements in the sterilization process will fuel the growth of the terminal sterilization market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13157

Terminal sterilization market has to gain attention over the past few years due to rising awareness about diseases and infection caused due to non-sterile environment. Besides, growing investment in healthcare infrastructure, research and focused on public health adaption of terminal sterilization is increasing significantly.

Furthermore, the rising prevalence of infectious disease, cancer, diabetes, autoimmune diseases anticipated accelerating the demand of for terminal sterilization services. This is especially true with increasing incidence of contagious disease such as bacterial and viral infections will increasing the demand for terminal sterilization.

COVID-19 pandemic Likely to Augment Demand of Terminal sterilization services 

Demand for terminal sterilization services increases around the globe due to COVID-19-pandemic. COVID-19 pandemic is expected to rise the demand for terminal sterilization services to overcome disease spread. For example, in 2020 April, the U.S. Food and Drug Administration approved the use of maX low-temperature sterilization systems, maX2, and Steris V-PRO 1 Plus for sterilization of equipment’s, respirators and other masks used in the treatment of COVID-19 patients in hospitals.

Furthermore, the healthcare facilities repeatedly require disinfection, sterilization, and cleaning process to decrease hospital-acquired infections. These factors will accelerate the demand for terminal sterilization services during the forecast period.

Who are the Key Manufacturers and Suppliers of Terminal sterilization?

Some of the leading manufacturers and suppliers of terminal sterilization include

  • Johnson And Johnson
  • DuPont
  • Steris Plc
  • Getinge Group
  • Advanced Sterilization Products Services, Inc
  • 3M
  • Belimed
  • Cantel Medical

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13157

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Sequencing Reagents Market Perspective, Comprehensive Analysis, Growth and Forecast 2021-2031

According to the latest research by Future Market Insights, the Sequencing Reagents market is set to witness steady growth during 2021-2031. Demand for sequencing reagents market will witness steady recovery in the short-term, with an optimistic growth outlook in the long run. The increase in demand for diagnostic and therapeutic application will provide momentum to the industry, however, social and ethical concerns related to sequencing methods is likely to hinder the market growth.

What is Driving Demand for Sequencing Reagents?

Diminishing costs of genetic sequencing and growing levels of adoption for third-generation sequencing techniques is expected to propel the growth of the sequencing reagent market. Third-generation sequencing techniques streamline the workflow and reduce the overall time required for the preparation step. Furthermore, during ligation process and genome fragmentation, it helps to simplify and improves the data quality and overall workflow.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13155

Additionally, the presence of appurtenant government programs has increased the expansion of ordering sequencing in distinguishing the genomic variations related to human diseases. For example, in Gregorian calendar month 2018, NHS European nation, in partnership with the genetics European nation, sequenced a hundred thousand whole genomes from NHS patients to uncover new diagnoses and treatment for patients with cancer and rare inheritable diseases.

Moreover, a rise in funding from public and personal entities has supplemented the expansion of high output technology, later on enhancing demand for his or her various reagents. For example, in March 2018, the German analysis Foundation-funded USD seventeen.3 million to four new German sequencing centres to equip them with NGS technology.

Advancements in sequencing Techniques Likely to Augment Sequencing Reagents Market

The advancement of technology enables researchers to sequence the entire genome within a short period at a lower cost. Novel technologies like Nanopre and Single-Molecule Real-Time (SMRT) sequencing, have been developed for effective and efficient development of sequencing libraries. This, not to mention the provision of recent commercial kits provides reagents for only a specific sequencing application, which further drives the market to grow.

The COVID-19 pandemic has caused havoc in the entire world. The healthcare crisis has brought an exceptional impact on businesses across all industries. During the outbreak, healthcare industries are hugely impacted due to global restrictions. However, the need for vaccination was the most important factor at the need of the hour. Ongoing research and development for the COVID19 vaccine increased which in turn favoured the growth for sequencing reagents market.

Who are the Key Manufacturers and Suppliers of Sequencing Reagents?

Some of the leading manufacturers and suppliers of Sequencing Reagents include

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • QIAGEN
  • BGI
  • Pacific Biosciences of California, Inc.
  • F. Hoffmann-La Roche AG
  • Oxford Nanopore Technologies
  • Agilent Technologies, Inc.
  • Fluidigm Corporation; ArcherDX, Inc.
  • Takara Bio Inc.
  • Bioline.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13155

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

HDL Cholesterol Kits Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2029

The growth of the HDL cholesterol kits market can be attributed to the increasing prevalence of atherosclerosis due to high cholesterol level, which favours the demand for cholesterol testing. According to the latest research by FMI, the global HDL cholesterol kits market is expected to be valued at US$ 790 Mn by the end of 2029. The HDL cholesterol kits market is expected to expand at a CAGR of 5.0% during the forecast period 2019-2029.

The increasing incidence of obesity and hyperlipidaemia among people is boosting the need for cholesterol testing, which is driving the growth of the HDL cholesterol kits market. The prevalence of obesity has increased from 33.7% in 2007-2008 to 39.7% in 2015-2016 among adults in the U.S. The increasing prevalence of obesity also increases the risk of cardiovascular disorders, high blood pressure, and hyperlipidaemia. Moreover, the prevalence of hyperlipidaemia is high among the obese population. Nearly 60-70% of patients suffering from obesity have hyperlipidaemia. Other factors, such as growing awareness programs for cholesterol testing and growing cholesterol testing among diabetic patients, are also propelling the growth of the HDL cholesterol kits market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9842

Rise of ‘Regular Health Check’ Trend Uplifts Prospects in East Asia

Low awareness in middle- and low-income countries about cholesterol testing and other healthcare testing are also among the major factors that are expected to hamper the growth of the HDL cholesterol kits market. There is low awareness about diseases such as dyslipidaemia and hypercholesterolemia in middle-income countries and rural areas. Moreover, the chances of errors and inaccuracy in HDL cholesterol testing methods, such HDL cholesterol precipitating method, are among factors expected to restrain the growth of the HDL cholesterol kits market.

The North America HDL cholesterol kits market gain a maximum value share in 2018. However, the East Asia HDL cholesterol kits market expected to witness prominent growth owing to the higher demand for cholesterol testing in countries such as China and Japan. Developing countries, such as China and India, represent a significant growth rate in the HDL cholesterol kits market due to the growing adoption of regular healthcare testing. The Middle East & Africa HDL cholesterol kits market is expected to witness a sluggish growth rate as compared to other regions.

The global HDL cholesterol kits market has been studied based on the product type and end user. Based on the product type, the HDL cholesterol kits market has been segmented into HDL cholesterol precipitating reagent kit, HDL cholesterol direct reagent kit, and HDL and LDL/VLDL assay kit. The HDL and LDL/VLDL assay kit product type segment is expected to hold a prominent share in the global HDL cholesterol kits market. Based on end user, the HDL cholesterol kits market has been segmented into hospitals, clinics, and diagnostic laboratories. In terms of revenue, the hospitals segment of the HDL cholesterol kits market was a significant market for HDL cholesterol kits in 2018.

Partnerships and Acquisitions Governing the Competition Landscape

Some of the key players operating in the HDL cholesterol kits market are Diazyme Laboratories, Inc., Randox Laboratories Limited, Fujifilm Holding Corporation, Thermo Fisher Scientific, Abcam plc., Merck KGaA, Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc.), PerkinElmer, Inc., and Hoffmann-La Roche Ltd.

Players in the HDL cholesterol kits market are focusing on partnerships and acquisitions with regional and global players to increase their sales worldwide. For instance, through the acquisition of Wako Pure Chemical, Fujifilm Holding Corporation expand its presence in the life science and chemical sectors. The manufacturers of HDL cholesterol kits are focusing on the expansion of their presence in key markets such as the Asia Pacific, the Middle East, and Europe through distribution agreements and the opening of new manufacturing facilities. The manufacturers of HDL cholesterol kits are also focusing on the development of point-of-care testing as it is more helpful and convenient for making quicker decisions. Moreover, HDL cholesterol kits industry stakeholders are focusing on the addition of direct reagent kits in their product portfolios.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9842

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

HIV/HBV/HCV Test Kits Market Covid-19 Impact Analysis, Size, Share, Key Trends, Demand and Forecast till 2028

The increasing burden of HIV and viral hepatitis infections is estimated to boost the HIV/HBV/HCV test kits market. Assay-based test kits are expected to contribute a large market share as these are the first line of tests prescribed to patients. Moreover, in most of the developing regions, healthcare professionals and patients rely on assay-based testing results. Increase in the number of initiatives undertaken by government organisations and NGOs to raise awareness regarding the available testing materials and treatment options is expected to boost the growth of the HIV/HBV/HCV test kits market over the forecast period.

The rising adoption of point-of-care testing is expected to boost the demand for rapid test kits and is anticipated to grow at a high rate during the forecast years. According to the latest report published by the FMI, the global HIV/HBV/HCV test kits market, in terms of market value, is expected to account for US$ 9.4 Bn by the forecast year 2029. The report further projects that the HIV/HBV/HCV test kits market will grow at an approximate CAGR of 7.0% during the forecast period 2019-2029.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9814

R&D, Clinical Trials, & Government Initiatives Collectively Provide Impetus

Over the past decades, HIV/HBV/HCV test kits have gained significant popularity and an upsurge in demand across the world. According to the United Nations Programme on HIV/AIDS (UNAIDS), the global prevalence of HIV was around 0.8% among adults in 2017, of which 75% of the people are aware of their HIV status. Of these, 79% are receiving treatment. The demand for combination rapid test kits is expected to grow at a high rate, which is estimated to contribute a high revenue share to the HIV/HBV/HCV test kits market over the forecast years. Combination rapid test kits provide the result for HIV, HBV, and HCV infection together by using one sample within 20 min to half an hour. This factor is expected to play an instrumental role in driving the growth of the HIV/HBV/HCV test kits market.

Lack of awareness regarding the available treatment options and the asymptomatic nature of infections is expected to hamper the growth of the HIV/HBV/HCV test kits market. In 2015, an estimated 257 Mn people were living with chronic hepatitis B infection, and 71 Mn people with chronic hepatitis C infection, due to lack of awareness regarding the symptoms. Hence, majority of the population remained underserved. The East Asia and Africa HIV/HBV/HCV test kits markets are expected to witness significant growth in the patient pool due to the high prevalence of infections in these regions, coupled with lack of awareness, poor healthcare infrastructure, and treatment facilities.

However, rising R&D and clinical trials, steps taken to reduce the cost of treatment, and initiatives by governments & NGOs to spread awareness and provide free check-up centres are some of the factors boosting the growth of the HIV/HBV/HCV test kits market. The East Asia HIV/HBV/HCV test kits market is estimated to create an approximate incremental $ opportunity worth US$ 7.7 Bn between 2019 and 2029.

The global HIV/HBV/HCV test kits market has been segmented by kit types, sample type, end user, and regions. Furthermore, the test kits type of HIV/HBV/HCV test kits market has been segmented into assay-based test kits, rapid test kits, and combination rapid test kits, which are used for the detection of HIV and viral hepatitis B & C infections. The sample type segment of the HIV/HBV/HCV test kits market is segmented into blood, urine, and saliva. Blood sample type is expected to hold a large share during the forecast period. In terms of end user, HIV/HBV/HCV test kits are segmented into hospitals, clinics, diagnostic laboratories, government organisations & NGOs, and others.

The report tracks some of the key companies operating in the HIV/HBV/HCV test kits market, such as Hoffmann-La Roche Ltd., Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN, Hologic Inc., Meridian Bioscience, Inc., Maternova, Siemens AG, and Creative Diagnostics.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9814

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Surgical Booms Market 2019: Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2029

Surgical booms are also known as Equipment Management Systems (EMS). Surgical booms are used to constrain electrical wiring from the various equipment used in the OR. They also help organise the space in the OR by increasing the working space. Most surgical booms are suspended from the roof of the OR and are available in a number of designs and utilities. According to the latest research by FMI, the global surgical booms market is expected to account for more than US$ 380 Million in terms of value by the end of 2029. The surgical booms market report also projects significant growth potential with an anticipated average Y-o-Y growth rate of over 4.5% during the forecast period.

Increase in the Adoption of Minimally Invasive Surgeries is Likely to Drive the Growth of the Surgical Booms Market

Minimally Invasive Surgery (MIS) is one of the major trends in medicine. MIS is a safe, feasible, and patient-friendly method of performing medical procedures such as surgery. MIS offers reduced postoperative pain, shorter length of stay in a hospital, lesser scarring or damage to tissues, and generally leads to faster recovery. Hence, MIS is easier and less time-consuming. As clinicians seek safer and more efficient ways to perform surgery, they find new applications for minimally invasive procedures, because the benefits of the same for patients are paramount. Furthermore, the increasing number of insurance providers that offer reimbursement for costs incurred during most minimally invasive procedures is expected to increase the adoption rate of minimally invasive surgeries. The Centers for Medicare and Medicaid Services (CMS) provides reimbursement for peripheral access procedures, such as the insertion of a port or catheter into a large central artery that is directly related to or is near the heart. Thus, increase in the number of minimally invasive surgeries is boosting the demand for equipment management systems such as equipment booms.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-4375

High Capital Investment for Integrated OR to Hinder the Growth of Surgical Booms Market

Integrated ORs utilise a crossover of medical interventions to form hybrid technologies. The development and integration of ORs requires the re-organization of professionals. In addition, there is a need to upgrade the capital equipment. Cost of such advanced capital equipment is high. Furthermore, compatibility with existing or new devices/infrastructure is likely to present a hurdle for the designers, manufacturers, and end users of surgical booms. A hybrid OR, on an average, requires 50-80% more space as compared to a conventional OR in the U.S., and 30-40% more in Germany. The additional space required is another factor that is likely to increase the cost of the setup of an integrated OR. Thus, the capital cost required for an integrated OR is likely to hinder the growth of the surgical booms market.

Surgical Booms Market: Segmental Analysis

The global surgical booms market has been segmented on the basis of product, installation, and end user. On the basis of product type, the surgical booms market has been segmented into equipment booms, utility booms, anaesthesia booms, and custom booms. Custom booms lead the market due to the flexibility of choice the customers have from manufacturers. Based on installation, the surgical booms market has been segmented into roof mounting and floor mounting. In terms of revenue, the roof mounting segment is expected to have a major share in the surgical booms market during the forecast period as these are more flexible and conserve space in the OR more effectively. On the basis of end user, the surgical booms market has been categorised into hospitals, ambulatory surgical centres, specialty clinics, and hybrid operating rooms. The revenue generated by the hospitals segment of the surgical booms market is expected to witness significant growth, which is driven by the presence of a large number of ORs and associated ICU departments at various hospitals.

Surgical Booms Market: Companies

Some of the key players in the surgical booms market include CV Medical LLC., Stryker Corporation, Hill Rom Holdings Inc., Amico Group of Companies, Steris Plc, Ondal Medical Systems GmbH, Getinge Group, Pratibha Medinox, Skytron LLc, and Palakkad Surgical Industries, among others.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-4375

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Clinical Oncology Next-Generation Sequencing Market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2029

Next-generation sequencing refers to the identification of the nucleotides of DNA base pairs for the diagnosis of various diseases. Oncology is one of the important applications of next-generation sequencing. It is an advanced and faster method of sequencing. Clinical oncology next-generation sequencing includes kits & reagents, services, sequencing platforms, and sequencing products. The kits and reagents used for sequencing are expected to witness significant growth in the overall market.

North America is expected to be a prominent region in the global clinical oncology next-generation sequencing market owing to the presence of well-developed healthcare infrastructure and numerous technological advancements in the region. North America and Europe are expected to witness a significant growth rate in the clinical oncology next-generation sequencing market.

Synthesis Sequencing Technology to Hold a Major Market Value Share

Based on the technology, the clinical oncology next-generation sequencing market has been segmented into pyro sequencing, sequencing by synthesis (SBS), and Single-Molecule Real-Time Sequencing (SMRT), nanopore sequencing, ligation sequencing, and reversible dye termination sequencing. Synthesis sequencing is however expected to hold a significant share in the clinical oncology next-generation sequencing market. Ion semiconductor sequencing is a method of DNA sequencing in which hydrogen ions are detected based on the polymerisation of DNA. Pyro-sequencing includes identifying the order of nucleotides in DNA based on the “sequencing by synthesis” principle, in which the sequencing is performed with the help of DNA polymerase. SBS is a technique used to determine the series of base pairs in DNA, which is also known as DNA sequencing.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9543

There are various applications associated with clinical oncology next-generation treatment market. They include whole tumor genome sequencing, whole tumour exome sequencing, targeted tumour genome profiling, tumour transcriptome sequencing, tumour-normal comparisons, and other applications. Targeted tumor genome profiling is expected to hold a large share of the clinical oncology next-generation treatment market. On the basis of end user, the clinical oncology next-generation sequencing market has been segmented into hospital laboratories, clinical research organisations, diagnostic laboratories, and others. Clinical research laboratories are expected to hold a large revenue share in the clinical oncology next-generation sequencing market.

Apart from the factors driving the clinical oncology next-generation sequencing market, there are few factors that are likely to hinder the overall growth of the clinical oncology next-generation sequencing market, such as high costs associated with the establishment of sequencing platforms, low quality of outsourcing services, and inadequate availability of sequencing platforms in some regional markets. On the other hand, increasing biomedical research using clinical oncology, increasing government funding for life science projects, substantial decline in the prices of sequencing, and technological advancements in the field of sequencing are some of the major factors driving the growth of the clinical oncology next-generation sequencing market.

Tier 1 Companies Hold Nearly 3/5th Share of Global Market Value

The report tracks some of the key companies operating in the clinical oncology next-generation sequencing market such as QIAGEN N.V., Thermo Fisher Scientific., Pacific Biosciences of California, Inc., F. Hoffmann-La Roche Ltd Oxford Nanopore Technologies, Ltd., Takara Bio, Inc., Illumina Inc., PerkinElmer Inc.and Agilent Technologies, Inc. Thermo Fischer Scientific, Oxford Nanopore Technologies Ltd., and Illumina are expected to hold a signficant share of the clinical oncology next-generation sequencing market. These first tier companies hold a share of approximately 60% in the clinical oncology next-generation sequencing market.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9543

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Gene Editing Tools Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2029

According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18% during the period 2019-2029.

The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9) segment is a leading segment in terms of revenue by product type in the gene editing tools market, and accounted for an approximate revenue share of 75% in 2018. CRISPR/Cas9 gene editing tools are most widely used by scientists to create transgenic animals that include zebrafish, pigs, mice, rats, and primates. Among all the distribution channels in the gene editing tools market, the academic and research institutes segment is expected to be most prominent segment, followed by biotech and pharmaceutical companies.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9544

Prevalence of Cancers and Rare Genetic Diseases Establish a Strong Base for Innovation of Gene Editing Tools

The rising prevalence of cancer and other genetic disorders, such as sickle cell disease, heart disease, diabetes, Alzheimer’s disease, obesity, and others, is among the key factors impacting the growth of gene editing tools market. Cancer is registered to be the second most prominent cause of death worldwide. According to the World Health Organization (WHO), the number of deaths due to cancer worldwide in 2015 was 8.8 million. However, cancer alone was responsible for an estimated 9.6 million deaths globally in 2018.

Worldwide, approximately about 1 in 6 deaths occur owing to cancer. An analysis states that approximately 70% of deaths due to cancer occur in low- and middle-income countries. Thus, gene editing is most preferred for the management of rare genetic disorders, which is driving the demand for gene editing, thus generating a favourable revenue opportunity for gene editing tools.

The growing prevalence and incidence of rare genetic disorders, majorly Sickle Cell Disease (SKD), cancer, and Alzheimer’s disease, is leading to the high demand for genome editing, and is one of the leading factors that is contributing significantly to the growth of the gene editing tools market. Moreover, gene editing tools, such as CRISPR, TALENs, and ZFNs, find precise applications in the treatment of cancer. Owing to the high efficiency and accuracy of the CRISPR-Cas9 gene editing technique, it has emerged as a potential tool for cancer therapy. Among its various applications, CRISPR-Cas9 has a high clinical potential to detect novel target genes for cancer therapy.

Biomedical Community Eyes Potential Application of Gene Editing Tools

Introduction of technologically advanced gene editing tools is expected to boost the growth of gene editing tools market. Recent advancements in CRISPR gene editing tools and their ease of use have generated significant interest in the biomedical community. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based gene editing has high potential to cater to the therapeutic landscape of induced disorders, owing to the presence of key players in the industry such as Intellia, CRISPR Therapeutics, and Editas. CRISPR gene editing tools offer precise gene-targeted treatments for β-thalassemia and SKD. Among gene editing tools, there are potential applications for CRISPR in the gene editing tools market in human therapeutics as well as veterinary therapeutics.

Regional Players Focusing on Product Reach & Connectivity

North America, followed by Europe, is a prominent region in the global gene editing tools market. North America accounts for a revenue share of about 25.0% in 2018 in gene editing tools market. Europe accounting for the second-largest revenue share, and is followed by South Asia in the gene editing tools market. India, China, and Japan are among the emerging markets in the gene editing tools market. Japan is among the fastest-growing emerging markets in the global gene editing tools market, and is projected to grow at a CAGR of more than 6% during the forecast period of 2018-2028.

The gene editing tools market report tracks some of the key companies operating in gene editing tools market, such as Thermo Fisher Scientific Inc., ERS Genomics, CRISPR THERAPEUTICS, Merck KGaA, Editas Medicine, Takara Bio USA, New England Biolabs, Intellia Therapeutics, Inc., and GenScript Biotech Corporation. Majority of the key regional players in the gene editing tools market are focused on increasing their product reach and connectivity with the help of domestic distributors of gene editing tools. Moreover, the manufacturers of gene editing tools are focused to strengthening their businesses in high-growth markets, such as India, Japan, China, and Argentina, by expanding their sales and distribution channels across these countries.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9544

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Shrimp Market Perspective, Comprehensive Analysis, Growth and Forecast 2021-2031

Increasing focus on maintaining good health especially as the world is witnessing various pandemic and epidemic outbreak has been increasing seafood consumption. Against this backdrop Future Market Insights (FMI), presents a positive outlook for the shrimps market. According to the report, the shrimps market is slated to register a CAGR of 6.7% between 2021 and 2031.

Shrimps being a very good source of protein,are increasingly included in food, pharmaceutical, cosmetics, and various industrial products. Consumers have become extremely health conscious owing to the increasing prevalence of various ailments and have become more willing to spend on sea food such as shrimps.

Shrimps have various properties that help in preventing and controlling cholesterol, obesity, heart attacks, and other health conditions. Increasing awareness regarding this is expected to result in high demand for shrimps in the coming years.

Skin care products containing ingredients derived from shrimps are proven to be very beneficial in skin tightening and skin rejuvenation as shrimp contains collagen which is very much needed for tissue repair. Skin cells can be renewed with regular intake of collagen. The upper layer of skin called as epidermis is the most delicate part of the skin.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1838

Consumption of shrimp in form either as a part of their regular diet or in the form of dietary supplements also offers various health benefits. According to the report, the food sector is expected to account for nearly70% of sales in the market through the forecast period.

Key Takeaways from the Shrimp Market Study

  • Despite restrictions amid pandemic, shrimps market is forecast to exhibit a little below 6% y-o-y growth in 2021
  • Increasing shrimp consumption will enable the U.S. account for over 80% sales in North America
  • The U.K. will continue dominating the Europe market, exhibiting 8.6% y-o-y growth in 2021
  • Seafood consumption is considerably high in Germany and France, catapulting them as lucrative markets for shrimps within Europe
  • China is the largest producer of shrimps and will continue dominating the East Asia market

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1838

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Liquid Breakfast Products Market Trend 2017, Growth, Leading Companies with Impact of Covid-19, Business Scenario, Emerging Dynamics, Industry Share and Revenue Forecast by 2027

Consumers across the world are demanding more natural, GMO-free and organic food products in their breakfast meals. A hectic and busy lifestyle is one of the significant elements that is pushing consumers towards increasing the consumption of ‘grab and go breakfast’ across the globe. Although consumers typically prefer ready-to-eat food and drinks in their breakfast, they are not ready to compromise with the source of ingredients. This is one of the key reasons that the global liquid breakfast market has been growing tremendously since last few years. The analysts of Future Market Insights have come up with a new report titled “Liquid Breakfast Products Market: Global Industry Analysis 2012-2016 and Opportunity Assessment 2017-2027.” The global liquid breakfast products market is anticipated to reach about 302,066 MT by 2017 end and is estimated to be pegged at about 515,341 MT by the end of 2027, registering a CAGR of 5.6%.

Key Manufacturer Strategies to Support Huge Global Demand for Liquid Breakfast Products

  • Introduction of products with reduced sugar and no artificial flavours / added colours
  • Elimination of undesirable ingredients such as artificial dyes and preservatives
  • Shift towards more natural and organic ingredient sources
  • Increased venture capital funding to identify upcoming brands
  • Acquisition of disruptive health and wellness brands

Apart from these strategies, manufacturers in the global liquid breakfast products market are likely to shift their focus on untapped markets such as India, China and Australia where consumer demand for liquid breakfast products is on the rise.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-4680

Global Liquid Breakfast Products Market: Forecast by Product Type

The global liquid breakfast products market is segmented on the basis of product type into liquid breakfast (Milk and Cereal Based Breakfast, Drinkable Yoghurt, Vegetable Liquid Soup, Chilled Soup) and spoonable breakfast. The spoonable breakfast segment is expected to grab the maximum market share – around 55% in 2017 – and is estimated to reach a market valuation of US$ 103.2 Bn by 2027 end. Growing demand for spoonable Greek yoghurt across the globe is expected to boost revenue growth of the spoonable breakfast product type segment.

Global Liquid Breakfast Products Market: Forecast by Packaging Type  

The global liquid breakfast products market is divided on the basis of packaging type into pouches, cups and tubs, bottles, carton packaging and cans. Cups and tubs are expected to grow 1.9x in terms of revenue in the global liquid breakfast products market. With a 6.6% CAGR, the cups and tubs segment is the largest segment in terms of revenue in the global market followed by the pouches segment at 6.3% CAGR. Increasing use of bottles as a preferred packaging option for drinkable yoghurt and chilled soups is expected to contribute towards segmental revenue growth, which is estimated to be about US$ 18.5 Bn by 2017 end.

Global Liquid Breakfast Products Market: Forecast by Distribution Channel

The global liquid breakfast products market is segmented on the basis of distribution channel into hypermarket/supermarket, retail stores, convenience stores, online selling, and other retail formats. Hypermarket/supermarket is the most attractive segment with an incremental $ opportunity of US$ 36.9 Bn between 2016 and 2027. Revenue from the convenience stores distribution channel segment is expected to increase 1.7X over the forecast period.

Global Liquid Breakfast Products Market: Regional Forecast

The global liquid breakfast products market has been studied across the seven key regions of North America, Latin America, Asia Pacific Excluding Japan, Western Europe, Eastern Europe, Japan, and Middle East & Africa. Western Europe is projected to be the most attractive and dominant regional market in the global liquid breakfast products market during the forecast period, accounting for a revenue share of 26.8% by 2027 end. The market for liquid breakfast products in APEJ is expected to generate a revenue of US$ 45.3 Bn by the end of 2027 with a CAGR of 6.2% during the forecast period.

Global Liquid Breakfast Market: Key Vendors

More than 15 key players and their performance in the global liquid breakfast products market have been featured in this report. Companies profiled include Sanitarium Health & Wellbeing, Danone, The Hain Daniels Group Limited, Campbell Soup Company, Tio Gazpacho LLC, Soupologie Limited, Kellogg Co., MOMA Foods, Weetabix Ltd., Nestle S.A., General Mills Inc., Quaker Oats Company, Müller UK & Ireland, Chobani, LLC, The Kraft Heinz Company, and The Billington Group.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-4680

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com